Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-26 @ 6:32 PM
Study NCT ID:
NCT01892293
Status:
TERMINATED
Last Update Posted:
2019-01-10
First Post:
2013-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CT Antigen TCR-Engineered T Cells for Myeloma
Sponsor:
Adaptimmune
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ADP-0011-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None